Heron Therapeutics Inc (HRTX)
1.19
-0.05
(-4.03%)
USD |
NASDAQ |
Nov 15, 16:00
1.20
+0.01
(+0.84%)
After-Hours: 20:00
Heron Therapeutics Free Cash Flow (Quarterly): 2.94M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.94M |
| June 30, 2024 | -5.241M |
| March 31, 2024 | -9.516M |
| December 31, 2023 | 2.205M |
| September 30, 2023 | -9.972M |
| June 30, 2023 | -27.44M |
| March 31, 2023 | -25.12M |
| December 31, 2022 | -37.95M |
| September 30, 2022 | -37.11M |
| June 30, 2022 | -28.70M |
| March 31, 2022 | -44.98M |
| December 31, 2021 | -45.65M |
| September 30, 2021 | -54.70M |
| June 30, 2021 | -63.31M |
| March 31, 2021 | -42.72M |
| December 31, 2020 | -55.05M |
| September 30, 2020 | -42.69M |
| June 30, 2020 | -58.03M |
| March 31, 2020 | -35.87M |
| December 31, 2019 | -30.88M |
| September 30, 2019 | -24.42M |
| June 30, 2019 | -25.27M |
| March 31, 2019 | -51.16M |
| December 31, 2018 | -36.96M |
| September 30, 2018 | -39.33M |
| Date | Value |
|---|---|
| June 30, 2018 | -62.06M |
| March 31, 2018 | -62.62M |
| December 31, 2017 | -48.28M |
| September 30, 2017 | -40.54M |
| June 30, 2017 | -32.52M |
| March 31, 2017 | -51.52M |
| December 31, 2016 | -39.21M |
| September 30, 2016 | -36.65M |
| June 30, 2016 | -28.19M |
| March 31, 2016 | -33.18M |
| December 31, 2015 | -23.45M |
| September 30, 2015 | -20.14M |
| June 30, 2015 | -16.02M |
| March 31, 2015 | -20.00M |
| December 31, 2014 | -13.88M |
| September 30, 2014 | -19.32M |
| June 30, 2014 | -12.75M |
| March 31, 2014 | -15.77M |
| December 31, 2013 | -9.794M |
| September 30, 2013 | -13.33M |
| June 30, 2013 | -10.93M |
| March 31, 2013 | -8.396M |
| December 31, 2012 | -6.551M |
| September 30, 2012 | -2.885M |
| June 30, 2012 | -4.015M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-63.31M
Minimum
Jun 2021
2.94M
Maximum
Sep 2024
-32.49M
Average
-36.49M
Median
Free Cash Flow (Quarterly) Benchmarks
| Journey Medical Corp | -5.176M |
| NovaBay Pharmaceuticals Inc | -2.063M |
| Palatin Technologies Inc | -6.477M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.453M |